David J. Watson

3.5k total citations · 2 hit papers
47 papers, 2.7k citations indexed

About

David J. Watson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Genetics. According to data from OpenAlex, David J. Watson has authored 47 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Cellular and Molecular Neuroscience and 7 papers in Genetics. Recurrent topics in David J. Watson's work include Estrogen and related hormone effects (7 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Neuroscience and Neuropharmacology Research (5 papers). David J. Watson is often cited by papers focused on Estrogen and related hormone effects (7 papers), Neurotransmitter Receptor Influence on Behavior (5 papers) and Neuroscience and Neuropharmacology Research (5 papers). David J. Watson collaborates with scholars based in United States, United Kingdom and France. David J. Watson's co-authors include K.C.F. Fone, John Dupré, Stephanie A. Ross, Beth C. Seidenberg, James A. Bolognese, N. Bellamy, Elliot Ehrich, A. P. Labhsetwar, Mark J. Millan and Florence Loiseau and has published in prestigious journals such as NeuroImage, The Journal of Clinical Endocrinology & Metabolism and The Journal of Physiology.

In The Last Decade

David J. Watson

47 papers receiving 2.6k citations

Hit Papers

STIMULATION OF INSULIN SECRETION BY GASTRIC INHIBITORY PO... 1973 2026 1990 2008 1973 2011 200 400 600

Peers

David J. Watson
Dominic P. Behan United States
S. S. C. YEN United States
J. Lincoln United Kingdom
John F. Wilber United States
David J. Watson
Citations per year, relative to David J. Watson David J. Watson (= 1×) peers Ludwik K. Malendowicz

Countries citing papers authored by David J. Watson

Since Specialization
Citations

This map shows the geographic impact of David J. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Watson more than expected).

Fields of papers citing papers by David J. Watson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Watson. The network helps show where David J. Watson may publish in the future.

Co-authorship network of co-authors of David J. Watson

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Watson. A scholar is included among the top collaborators of David J. Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Watson. David J. Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Millan, Mark J., Anne Dekeyne, Alain P. Gobert, et al.. (2020). Dual-acting agents for improving cognition and real-world function in Alzheimer’s disease: Focus on 5-HT6 and D3 receptors as hubs. Neuropharmacology. 177. 108099–108099. 27 indexed citations
4.
Devonshire, Ian M., James J. Burston, Luting Xu, et al.. (2017). Manganese-enhanced magnetic resonance imaging depicts brain activity in models of acute and chronic pain: A new window to study experimental spontaneous pain?. NeuroImage. 157. 500–510. 13 indexed citations
5.
Watson, David J., Madeleine V. King, István Gyertyán, et al.. (2015). The dopamine D 3 -preferring D 2 /D 3 dopamine receptor partial agonist, cariprazine, reverses behavioural changes in a rat neurodevelopmental model for schizophrenia. European Neuropsychopharmacology. 26(2). 208–224. 45 indexed citations
6.
Meffre, Julie, Séverine Chaumont‐Dubel, Clotilde Mannoury la Cour, et al.. (2012). 5‐HT 6 receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. EMBO Molecular Medicine. 4(10). 1043–1056. 134 indexed citations
7.
Watson, David J., C.A. Marsden, Mark J. Millan, & K.C.F. Fone. (2011). Blockade of dopamine D3 but not D2 receptors reverses the novel object discrimination impairment produced by post-weaning social isolation: implications for schizophrenia and its treatment. The International Journal of Neuropsychopharmacology. 15(4). 471–484. 65 indexed citations
8.
Watson, David J. & Daniel J. Strom. (2011). RADIATION DOSES TO MEMBERS OF THE U.S. POPULATION FROM UBIQUITOUS RADIONUCLIDES IN THE BODY: PART 3, RESULTS, VARIABILITY, AND UNCERTAINTY. Health Physics. 100(4). 402–416. 1 indexed citations
9.
Watson, David J. & Daniel J. Strom. (2011). RADIATION DOSES TO MEMBERS OF THE U.S. POPULATION FROM UBIQUITOUS RADIONUCLIDES IN THE BODY: PART 1, AUTOPSY AND IN VIVO DATA. Health Physics. 100(4). 359–376. 2 indexed citations
10.
Strom, Daniel J., et al.. (2011). Disaggregating measurement uncertainty from population variability and Bayesian treatment of uncensored results. Radiation Protection Dosimetry. 149(3). 251–267. 2 indexed citations
11.
Dekeyne, Anne, Mauricette Brocco, Florence Loiseau, et al.. (2011). S32212, a Novel Serotonin Type 2C Receptor Inverse Agonist/α2-Adrenoceptor Antagonist and Potential Antidepressant: II. A Behavioral, Neurochemical, and Electrophysiological Characterization. Journal of Pharmacology and Experimental Therapeutics. 340(3). 765–780. 26 indexed citations
12.
Watson, David J. & Daniel J. Strom. (2011). RADIATION DOSES TO MEMBERS OF THE U.S. POPULATION FROM UBIQUITOUS RADIONUCLIDES IN THE BODY: PART 2, METHODS AND DOSE CALCULATIONS. Health Physics. 100(4). 377–401. 2 indexed citations
14.
Watson, David J., et al.. (2011). Animal models of schizophrenia. British Journal of Pharmacology. 164(4). 1162–1194. 564 indexed citations breakdown →
15.
Millan, Mark J., Jerry J. Buccafusco, Florence Loiseau, et al.. (2010). The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures. The International Journal of Neuropsychopharmacology. 13(8). 1035–1051. 65 indexed citations
16.
Braden, Gregory L., et al.. (1997). Ritodrine- and terbutaline-induced hypokalemia in preterm labor: Mechanisms and consequences. Kidney International. 51(6). 1867–1875. 34 indexed citations
17.
Thorneycroft, Ian H., et al.. (1988). Beta human chorionic gonadotropin levels in cul-de-sac blood of patients with ectopic pregnancies. Fertility and Sterility. 49(1). 166–167. 3 indexed citations
18.
Bell, F. R., D. A. Titchen, & David J. Watson. (1977). The effects of the gastrin analogue, pentagastrin, on the gastric electromyogram and abomasal emptying in the calf. Research in Veterinary Science. 23(2). 165–170. 17 indexed citations
19.
Watson, David J., et al.. (1973). OVARIAN SECRETION OF OESTRADIOL, OESTRONE, 20-DIHYDROPROGESTERONE AND PROGESTERONE DURING THE OESTROUS CYCLE OF THE GUINEA-PIG. Reproduction. 35(1). 177–181. 52 indexed citations
20.
Besch, Paige K., et al.. (1962). ADRENOCORTICAL STEROID PROFILE IN THE HYPERTENSIVE DOG. European Journal of Endocrinology. 39(3). 355–370. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026